Gardasil Gains Blockbuster Status In Its First Year On The Market

Merck’s HPV vaccine generated $1.1 billion in sales year-to-date, firm reports during third quarter earnings call.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet